Atorvastatin Calcium Hydrate/Irbesartan

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtorvastatin Calcium Hydrate/Irbesartan
Drug Alias NameAtorvastatin Calcium Hydrate•Irbesartan阿托伐他汀/厄贝沙坦厄贝沙坦•阿托伐他汀Atorvastatin Calcium Hydrate and Irbesartan厄贝沙坦/阿托伐他汀 +[17] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsHyperlipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/11/08
Country/TerritorySouth Korea
CombinationsYes IrbesartanAtorvastatin Calcium Hydrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksN/A